Medical Design & Outsourcing

4 days ago | medicaldesignandoutsourcing.com | Jim Hammerand

Nitinol innovation in cardiac medtech is not slowing down in 2025, with new devices and systems hitting milestones as device developers put the latest learnings about this nickel-titanium alloy to work. We’ll update this page throughout the year. In the meantime, you can visit Medical Design & Outsourcing‘s new nitinol hub to keep up with our latest nitinol news and coverage.

4 days ago | medicaldesignandoutsourcing.com | Carrie Pallardy

The Food and Drug Administration (FDA)  plans to launch generative AI across all of its centers by June 30. The announcement follows the appointment of the agency’s first chief AI officer, Jeremy Walsh, and the completion of an AI-assisted scientific review pilot. The generative AI rollout will allow FDA staff to spend less time on “tedious, repetitive tasks,” ultimately making the review process more efficient, according to the agency.

5 days ago | medicaldesignandoutsourcing.com | Jim Hammerand

Johnson & Johnson MedTech’s Sandeep Makkar discusses customer empathy and determining user needs for device design and development. It’s not easy for medical device designers and engineers to get into an operating room to observe procedures in search of better solutions. And when you get the opportunity ask a device user about their pain points, they might not even know what they really need.

1 week ago | medicaldesignandoutsourcing.com | Jim Hammerand

Siemens Healthineers reported single-digit increases in compensation for its CEO and human resources chief, along with pay decreases for two other leaders. Recruiting and retaining top talent — both at the executive and engineering level — is crucial in the medtech industry, but employee compensation is kept secret in most cases. Medical Design & Outsourcing tracks and analyzes these pay figures when disclosed by major device developers and manufacturers.

1 week ago | medicaldesignandoutsourcing.com | Sean Whooley

ClorDiSys announced recently that it received a U.S. patent for a system that can expand its sterilization capabilities. The patent enables the conversion of existing ethylene oxide (EtO) vacuum sterilizers to chlorine dioxide vacuum sterilizers. It enables greater expansion of the sterilization modality and can help decrease the barrier to entry for sterilization facilities without existing infrastructure when they seek to transition away from EtO sterilization technology.